VSee Health, Inc. Investment Income, Interest
VSee Health, Inc. (VSEE) reported Investment Income, Interest of $17.85 thousand for the 3-month period ending 2024-03-31, per its 10-Q filed 2024-05-15.
Discontinued › Income Statement
us-gaap:InvestmentIncomeInterest · last filed 2024-05-15
- VSee Health, Inc. investment income, interest for the quarter ending 2024-03-31 was $17.85K, a 76.28% decline year-over-year.
- VSee Health, Inc. investment income, interest for the quarter ending 2023-12-31 was $56.91K, a 87.42% decline year-over-year.
- VSee Health, Inc. investment income, interest for the quarter ending 2023-09-30 was $104.41K, a 73.34% decline year-over-year.
- VSee Health, Inc. investment income, interest for the quarter ending 2023-06-30 was $122.17K, a 94.83% increase year-over-year.
- VSee Health, Inc. investment income, interest for fiscal 2023 was $358.77K, a 61.12% decline from fiscal 2022.
- VSee Health, Inc. investment income, interest for fiscal 2022 was $922.64K.
| Period end | Investment Income, Interest 3 month | Investment Income, Interest 6 month | Investment Income, Interest 9 month | Investment Income, Interest 12 month |
|---|---|---|---|---|
| 2024-03-31 | $17.85K 10-Q · filed 2024-05-15 | $74.76K derived: sum of 2 quarters · filed 2024-05-15 | $179.17K derived: sum of 3 quarters · filed 2024-05-15 | $301.34K derived: sum of 4 quarters · filed 2024-05-15 |
| 2023-12-31 | $56.91K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-12 | $161.32K derived: sum of 2 quarters · filed 2024-04-12 | $283.49K derived: sum of 3 quarters · filed 2024-04-12 | $358.77K 10-K · filed 2024-04-12 |
| 2023-09-30 | $104.41K 10-Q · filed 2023-11-20 | $226.58K derived: sum of 2 quarters · filed 2023-11-20 | $301.86K 10-Q · filed 2023-11-20 | $754.35K derived: sum of 4 quarters · filed 2024-05-15 |
| 2023-06-30 | $122.17K 10-Q · filed 2023-08-21 | $197.45K 10-Q · filed 2023-08-21 | $649.94K derived: sum of 3 quarters · filed 2024-05-15 | $1.04M derived: sum of 4 quarters · filed 2024-05-15 |
| 2023-03-31 | $75.28K 10-Q · filed 2024-05-15 | $527.77K derived: sum of 2 quarters · filed 2024-05-15 | $919.40K derived: sum of 3 quarters · filed 2024-05-15 | $982.11K derived: sum of 4 quarters · filed 2024-05-15 |
| 2022-12-31 | $452.49K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-12 | $844.12K derived: sum of 2 quarters · filed 2024-04-12 | $906.83K derived: sum of 3 quarters · filed 2024-04-12 | $922.64K 10-K · filed 2024-04-12 |
| 2022-09-30 | $391.63K 10-Q · filed 2023-11-20 | $454.33K derived: sum of 2 quarters · filed 2023-11-20 | $470.15K 10-Q · filed 2023-11-20 | |
| 2022-06-30 | $62.70K 10-Q · filed 2023-08-21 | $78.52K 10-Q · filed 2023-08-21 | ||
| 2022-03-31 | $15.82K 10-Q · filed 2023-05-15 | |||
| 2021-12-31 | $1.97K 10-K · filed 2023-04-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Agape ATP Corp (ATPC) | $0.002B | ||
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |